Our study demonstrated a statistically significant correlation between HER2/neu staining and lymph node metastasis, with six cases exhibiting HER2/neu overexpression in metastatic lymph nodes. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.